Koers Eone Diagnomics Genome Center Co., Ltd.
Aandelen
A245620
KR7245620000
Farmaceutische producten
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
415 KRW | -5,25% | 0,00% | -0,72% |
Omzet 2022 | 94,24 mld. 68,14 mln. 64,09 mln. | Omzet 2023 | 88,46 mld. 63,95 mln. 60,15 mln. | Marktkapitalisatie | 48,88 mld. 35,34 mln. 33,24 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -29,86 mld. -21,59 mln. -20,31 mln. | Nettowinst (verlies) 2023 | -33,03 mld. -23,88 mln. -22,46 mln. | EV/omzet 2022 | 2,49 x |
Nettoschuld 2022 | 78,25 mld. 56,58 mln. 53,21 mln. | Nettoschuld 2023 | 61,28 mld. 44,31 mln. 41,67 mln. | EV/omzet 2023 | 1,25 x |
K/w-verhouding 2022 |
-5,15
x | K/w-verhouding 2023 |
-1,14
x | Werknemers | 103 |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 86,91% |
1 dag | -5,25% | ||
Lopende maand | -12,08% | ||
1 maand | -17,66% | ||
3 maanden | +4,27% | ||
6 maanden | -46,38% | ||
Lopend jaar | -0,72% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Shang Cheol Shin
CEO | Chief Executive Officer | - | - |
Min-Seob Lee
CEO | Chief Executive Officer | 58 | 01-02-13 |
Sam Martin
PRN | Corporate Officer/Principal | 46 | 13-09-22 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Gyu-Yeon Lee
BRD | Director/Board Member | 60 | - |
Min-Seob Lee
CEO | Chief Executive Officer | 58 | 01-02-13 |
Sung Ho Kim
BRD | Director/Board Member | - | - |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-0,72% | 41,69 mln. | |
+12,06% | 68,18 mld. | |
+5,16% | 25,78 mld. | |
+4,48% | 7,99 mld. | |
-3,37% | 7,88 mld. | |
-23,97% | 7,62 mld. | |
-0,67% | 4,48 mld. | |
+20,68% | 4,45 mld. | |
-4,23% | 3,89 mld. | |
-3,99% | 3,82 mld. |